95 related articles for article (PubMed ID: 21188325)
1. NAT2 polymorphisms and sporadic colorectal cancer survival.
Osian G; Procopciuc L; Vlad L; Iancu C; Cristea PG; Mocan T; Mocan L
J Gastrointestin Liver Dis; 2010 Dec; 19(4):361-8. PubMed ID: 21188325
[TBL] [Abstract][Full Text] [Related]
2. NAT2 gene polymorphism and sporadic colorectal cancer. Prevalence, tumor stage and prognosis. A preliminary study in 70 patients.
Osian G; Procopciuc L; Vlad L
J Gastrointestin Liver Dis; 2006 Dec; 15(4):347-53. PubMed ID: 17205146
[TBL] [Abstract][Full Text] [Related]
3. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
[TBL] [Abstract][Full Text] [Related]
4. N-acetyltransferase 2 gene polymorphism in patients with colorectal carcinoma.
Tamer L; Ercan B; Ateş NA; Değirmenci U; Unlü A; Ateş C; Dirlik M; Atik U
Cell Biochem Funct; 2006; 24(2):131-5. PubMed ID: 15617035
[TBL] [Abstract][Full Text] [Related]
5. GSTM1-null genotype as a risk factor for sporadic colorectal cancer in a Romanian population. Association with the NAT2-rapid-acetylator phenotype and exposure to environmental factors.
Procopciuc LM; Osian G
Cancer Invest; 2014 Feb; 32(2):53-62. PubMed ID: 24467372
[TBL] [Abstract][Full Text] [Related]
6. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer.
Bell DA; Stephens EA; Castranio T; Umbach DM; Watson M; Deakin M; Elder J; Hendrickse C; Duncan H; Strange RC
Cancer Res; 1995 Aug; 55(16):3537-42. PubMed ID: 7627961
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer.
Chen J; Stampfer MJ; Hough HL; Garcia-Closas M; Willett WC; Hennekens CH; Kelsey KT; Hunter DJ
Cancer Res; 1998 Aug; 58(15):3307-11. PubMed ID: 9699660
[TBL] [Abstract][Full Text] [Related]
8. NAT2 fast acetylator genotype is associated with an increased risk of colorectal cancer in Taiwan.
Huang CC; Chien WP; Wong RH; Cheng YW; Chen MC; Chou MC; Lee H
Dis Colon Rectum; 2007 Jul; 50(7):981-9. PubMed ID: 17525862
[TBL] [Abstract][Full Text] [Related]
9. NAT2 fast acetylator genotype and MGMT promoter methylation may contribute to gender difference in K-RAS mutation occurrence in Taiwanese colorectal cancer.
Huang CC; Chien WP; Wong RH; Cheng YW; Chen MC; Lee H
Environ Mol Mutagen; 2009 Mar; 50(2):127-33. PubMed ID: 19107910
[TBL] [Abstract][Full Text] [Related]
10. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in xenobiotic clearance genes and their influence on disease expression in hereditary nonpolyposis colorectal cancer patients.
Talseth BA; Meldrum C; Suchy J; Kurzawski G; Lubinski J; Scott RJ
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2307-10. PubMed ID: 17119063
[TBL] [Abstract][Full Text] [Related]
14. The association between N-acetyltransferase 2 gene polymorphisms and pancreatic cancer.
Ayaz L; Ercan B; Dirlik M; Atik U; Tamer L
Cell Biochem Funct; 2008 Apr; 26(3):329-33. PubMed ID: 18027363
[TBL] [Abstract][Full Text] [Related]
15. Colorectal adenomatous and hyperplastic polyps: smoking and N-acetyltransferase 2 polymorphisms.
Potter JD; Bigler J; Fosdick L; Bostick RM; Kampman E; Chen C; Louis TA; Grambsch P
Cancer Epidemiol Biomarkers Prev; 1999 Jan; 8(1):69-75. PubMed ID: 9950242
[TBL] [Abstract][Full Text] [Related]
16. Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk.
Le Marchand L; Hankin JH; Wilkens LR; Pierce LM; Franke A; Kolonel LN; Seifried A; Custer LJ; Chang W; Lum-Jones A; Donlon T
Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1259-66. PubMed ID: 11751443
[TBL] [Abstract][Full Text] [Related]
17. Prospective study of NAT1 and NAT2 polymorphisms, tobacco smoking and meat consumption and risk of colorectal cancer.
Sørensen M; Autrup H; Olsen A; Tjønneland A; Overvad K; Raaschou-Nielsen O
Cancer Lett; 2008 Aug; 266(2):186-93. PubMed ID: 18372103
[TBL] [Abstract][Full Text] [Related]
18. The CYP1A2-164A-->C polymorphism (CYP1A2*1F) is associated with the risk for colorectal adenomas in humans.
Moonen H; Engels L; Kleinjans J; Kok Td
Cancer Lett; 2005 Nov; 229(1):25-31. PubMed ID: 16157215
[TBL] [Abstract][Full Text] [Related]
19. [N-actyltransferase2 polymorphism in recurrence of colorectal polyps and adenomas].
Zheng S; Liu X; Cao J
Zhonghua Yi Xue Za Zhi; 2001 Aug; 81(15):907-9. PubMed ID: 11702663
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
Kralovánszky J; Adleff V; Hitre E; Pap E; Réti A; Komlósi V; Budai B
Magy Onkol; 2007; 51(2):113-25. PubMed ID: 17660867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
